Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioAtla (BCAB) Cash from Investing Activities (2020 - 2023)

BioAtla (BCAB) has disclosed Cash from Investing Activities for 4 consecutive years, with -$8000.0 as the latest value for Q4 2023.

  • For Q4 2023, Cash from Investing Activities rose 74.19% year-over-year to -$8000.0; the TTM value through Sep 2024 reached -$8000.0, up 93.39%, while the annual FY2023 figure was -$98000.0, 63.02% up from the prior year.
  • Cash from Investing Activities hit -$8000.0 in Q4 2023 for BioAtla, up from -$25000.0 in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at -$8000.0 in Q4 2023 and bottomed at -$501000.0 in Q1 2021.
  • Average Cash from Investing Activities over 4 years is -$117312.5, with a median of -$62000.0 recorded in 2020.
  • Year-over-year, Cash from Investing Activities crashed 2405.0% in 2021 and then soared 98.0% in 2022.
  • BioAtla's Cash from Investing Activities stood at -$395000.0 in 2020, then surged by 77.47% to -$89000.0 in 2021, then soared by 65.17% to -$31000.0 in 2022, then soared by 74.19% to -$8000.0 in 2023.
  • According to Business Quant data, Cash from Investing Activities over the past three periods came in at -$8000.0, -$25000.0, and -$15000.0 for Q4 2023, Q3 2023, and Q2 2023 respectively.